Osino Announces Upsizing of Previously Announced Private Placement

Written by Customer Service on October 14, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, Oct. 14, 2021 (GLOBE NEWSWIRE) — Osino Resources Corp. (TSXV:OSI) (FSE:RSR1) (OTCQB:OSIIF) (“Osino” or “the Company”) is pleased to announce that it has increased the size of the private placement (the “Private Placement“) announced in a news release dated October 13, 2021 due to investor demand. Osino now plans to issue up to an additional 4,545,455 units (“Units“) on the same terms as the Private Placement. Accordingly, the Private Placement will consist of up to a total of up to 9,454,455 Units at a price of $1.10 per Unit for aggregate gross proceeds of up to $10,500,000.50. Each Unit will consist of one common share (a “Share“) and one-half of one common share purchase warrant, and each such whole warrant will entitle the holder to purchase one additional...

XORTX Announces Results from Mount Sinai’s COVID-19 Clinical Study

Written by Customer Service on October 14, 2021. Posted in Public Companies.

Early, High Uric Acid is Independently Associated with Acute Kidney Injury and Mortality in COVID-19 CALGARY, Alberta, Oct. 14, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce and share the results of an American Society of Nephrology Kidney Week abstract by Dr. Steven Coca and team at Mount Sinai Hospital Network and Icahn School of Medicine, that will be published online Friday, October 15, 2021. This study was sponsored by XORTX Therapeutics Inc. and the reported findings support the provisional patent and applications filed by XORTX announced March 2020 and March 2021. This clinical study of patients hospitalized due to...

Glatfelter Announces Pricing of 4.750% Senior Notes Offering

Written by Customer Service on October 14, 2021. Posted in Public Companies.

CHARLOTTE, N.C., Oct. 14, 2021 (GLOBE NEWSWIRE) — Glatfelter Corporation (“Glatfelter” or the “Company”) (NYSE: GLT) announced today that it has priced its offering of $500 million in aggregate principal amount of 4.750% senior notes due 2029 (the “Notes”). The offering of the Notes is expected to close on October 25, 2021, subject to certain closing conditions. Each of the Company’s existing and future domestic restricted subsidiaries that guarantees the Company’s obligations under the Company’s credit facility (“Credit Facility”), which includes the Company’s revolving credit facility and term loan A facility, and/or certain other indebtedness, will guarantee the Notes on a senior unsecured basis. The net proceeds from the offering of the Notes, together with cash on hand, are expected to be used to pay the purchase price of...

Mercury Acquisitions Corp. Enters Into Amalgamation Agreement With Franchise Cannabis Corp. in Respect of Proposed Qualifying Transaction, With Resulting Issuer to Be Named “Franchise Global Health Inc.”

Written by Customer Service on October 14, 2021. Posted in Mergers And Acquisitions.

TORONTO, Oct. 14, 2021 (GLOBE NEWSWIRE) — Mercury Acquisitions Corp. (“Mercury”) (TSXV: MERC.P) is pleased to announce that it has entered into an amalgamation agreement dated October 14, 2021 (the “Amalgamation Agreement”) with Franchise Cannabis Corp. (“Franchise”) and 2868303 Ontario Inc., a wholly-owned subsidiary of Mercury (“Mercury Subco”), pursuant to which Mercury Subco will amalgamate with Franchise (the “Amalgamation”) to complete Mercury’s qualifying transaction (the “Transaction”) in accordance with the policies of the TSX Venture Exchange (the “TSXV”). The Amalgamation is structured as a three-cornered amalgamation and, as a result, the amalgamated corporation (“Amalco”) will be a wholly-owned subsidiary of Mercury at the time of completion of the Amalgamation. Upon completion of the Amalgamation, it is intended that...

PennantPark Investment Corporation Prices Public Offering of $165 Million 4.00% Unsecured Notes Due 2026

Written by Customer Service on October 14, 2021. Posted in Public Companies.

NEW YORK, Oct. 14, 2021 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NASDAQ: PNNT) announced that it has priced an underwritten public offering of $165 million in aggregate principal amount of its 4.00% unsecured notes due 2026 (the “Notes”). The Notes will mature on November 1, 2026 and may be redeemed in whole or in part at the Company’s option at any time at par plus a “make-whole” premium, if applicable; provided that the Notes may be redeemed at par three months prior to their maturity. The Notes will bear interest at a rate of 4.00% per year payable semi-annually on May 1 and November 1 of each year, beginning May 1, 2022. The offering is expected to close on October 21, 2021, subject to customary closing conditions. Raymond James & Associates, Inc., Keefe, Bruyette & Woods, A Stifel Company,...

IBC Advanced Alloys Announces Closing of Initial US$1,500,000 Funding by The Lind Partners

Written by Customer Service on October 14, 2021. Posted in Public Companies.

Construction of New State-of-the-Art Copper Alloys Foundry Moves Closer to Expected Completion in November 2021 [NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR FOR DISSEMINATION IN THE UNITED STATES] FRANKLIN, Ind., Oct. 14, 2021 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) announces that it has closed on initial funding under the previously announced convertible security funding agreement (the “Agreement”) with Lind Global Fund II, LP, managed by The Lind Partners, LLC, a New York based institutional fund manager (together, the “Investor” or “Lind”). “This funding from The Lind Partners essentially completes the capital raise we launched to fund expansion and consolidation of our Copper Alloys division’s state-of-the-art foundry facility at our North American headquarters in Franklin,...

AGTC Announces Two Key Leadership Team Appointments

Written by Customer Service on October 14, 2021. Posted in Public Companies.

– AGTC Welcomes Susan Schneider as the Chief Medical Officer and Sarah C. DiSalvatore as the Vice President of Clinical Operations – GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal diseases (IRDs), today announced the appointment of Susan Schneider, M.D., as Chief Medical Officer (CMO) and Sarah C. DiSalvatore, M.P.H., as Vice President of Clinical Operations. “We are excited to welcome Dr. Susan Schneider and Ms. Sarah DiSalvatore to AGTC during a pivotal time in our company’s history as we advance our X-Linked Retinitis Pigmentosa program into late-stage clinical development and prepare...

IBI Group Inc. to Announce Third Quarter 2021 Results and Host Conference Call / Webcast

Written by Customer Service on October 14, 2021. Posted in Public Companies.

TORONTO, Oct. 14, 2021 (GLOBE NEWSWIRE) — IBI Group Inc. (TSX: IBG) (“IBI” or the “Company”) today confirms the Company intends to release its financial and operating results for the three and nine months ended September 30, 2021 after markets close on Thursday, November 4th, 2021. The Company will host a conference call on Friday, November 5th, 2021 at 8:30 a.m. ET during which IBI’s Chief Executive Officer, Scott Stewart, and Chief Financial Officer, Stephen Taylor, will discuss the Company’s financial and operating results followed by a question-and-answer session. A live audio webcast of this call is available by entering the following URL into your web browser: https://produceredition.webcasts.com/starthere.jsp?ei=1502562&tp_key=4226f5c475 Conference Call Details: Date: Friday, November 5th, 2021Time: 8:30 a.m. ETDial...

Aligos Therapeutics to Present Data for its Clinical Portfolio Targeting Chronic Hepatitis B and NASH at AASLD’S The Liver Meeting® 2021

Written by Customer Service on October 14, 2021. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced upcoming poster presentations highlighting data relating to its chronic hepatitis B (CHB) and nonalcoholic steatohepatitis (NASH) clinical programs at The Liver Meeting® 2021, hosted by the American Association for the Study of Liver Diseases (AASLD), being held virtually November 12 – 15, 2021. All posters presented will be available on the Aligos website at Scientific Presentations & Conferences following the conclusion of the conference. Chronic Hepatitis B S-antigen Transport-inhibiting Oligonucleotide Polymers (STOPSTM) Title: S-antigen Transport-inhibiting...

Paltalk, Inc. Announces Proposed Public Offering of Common Stock

Written by Customer Service on October 14, 2021. Posted in Public Companies.

JERICHO, NY, Oct. 14, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Paltalk, Inc. (Nasdaq: PALT) (“Paltalk,” the “Company,” “we,” “our” or “us”), a leading communications software innovator that powers multimedia social applications, today announced it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, Paltalk intends to grant the underwriters a 45-day option to purchase up to an additional 15 percent of the number of shares of its common stock offered in the public offering. Paltalk currently intends to use the net proceeds from the offering to fund development costs related to new and existing applications,...

Day: October 14, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice